Patents-Review.com
🔗 Permalink
Assignee profile:

BAYER PHARMACEUTICALS CORPORATION

City:

Berkeley, California

Country:

United States

Published Applications:

8

Last publication date:

2013-12-12

Patent Grants:

7

Last grant date:

2014-07-08

Top Inventors for applications by BAYER PHARMACEUTICALS CORPORATION

These are the the leading inventors for applications assigned to BAYER PHARMACEUTICALS CORPORATION:

Recent patent applications by BAYER PHARMACEUTICALS CORPORATION

BAYER PHARMACEUTICALS CORPORATION based in Berkeley, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-12-12 ✅ Patent 8,772,027 granted on 2014-07-08
US20130330820A1
Chemistry; metallurgy

Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells

 #2 | 2013-12-12 ✅ Patent 8,765,466 granted on 2014-07-01
US20130330819A1
Chemistry; metallurgy

Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells

 #3 | 2013-07-25
US20130189776A1
Chemistry; metallurgy

Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells

 #4 | 2013-04-02 ✅ Patent 8,409,857 granted on 2013-04-02
US13464543
-

Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells

 #5 | 2012-01-12 ✅ Patent 8,192,985 granted on 2012-06-05
US20120009670A1
Chemistry; metallurgy

Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells

 #6 | 2009-04-23 ✅ Patent 7,951,588 granted on 2011-05-31
US20090104664A1
Chemistry; metallurgy

Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells

 #7 | 2005-10-18 ✅ Patent 6,955,807 granted on 2005-10-18
US9341351
-

IL-2 selective agonists and antagonists

 #8 | 2005-03-03 ✅ Patent 7,244,616 granted on 2007-07-17
US20050048608A1
Chemistry; metallurgy

Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells

Also check out Bayer Pharmaceuticals Corporation's (Berkeley, United States) applicant profile with 3 patent applications submitted.

AssigneeID:

31712 ⎘